1	Control	Control	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	activity	activity	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	I	i	_	_	_	_	_	_	_
9	kappa	kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	beta	beta	_	_	_	_	_	_	_
12	inhibitor	inhibitor	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	transcription	transcription	_	_	_	_	_	_	_
3	factor	factor	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	maintained	maintain	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	inactive	inactive	_	_	_	_	_	_	_
11	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
12	state	state	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	I	i	_	_	_	_	_	_	_
15	kappa	kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	inhibitors	inhibitor	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	mammalian	mammalian	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	I	i	_	_	_	_	_	_	_
6	kappa	kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	alpha	alpha	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	I	i	_	_	_	_	_	_	_
11	kappa	kappa	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	beta	beta	_	_	_	_	_	_	_
14	proteins	protein	_	_	_	_	_	_	_
15	have	have	_	_	_	_	_	_	_
16	been	be	_	_	_	_	_	_	_
17	purified	purify	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	shown	show	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	be	be	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	inhibitors	inhibitor	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	NF-kappa	NF-kappa	_	_	_	_	_	_	_
26	B	B	_	_	_	_	_	_	_
27	through	through	_	_	_	_	_	_	_
28	their	their	_	_	_	_	_	_	_
29	association	association	_	_	_	_	_	_	_
30	with	with	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	p65	p65	_	_	_	_	_	_	_
33	or	or	_	_	_	_	_	_	_
34	c-Rel	c-rel	_	_	_	_	_	_	_
35	subunits	subunit	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	we	we	_	_	_	_	_	_	_
5	have	have	_	_	_	_	_	_	_
6	isolated	isolate	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	third	third	_	_	_	_	_	_	_
9	NF-kappa	NF-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	inhibitor	inhibitor	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	I	i	_	_	_	_	_	_	_
14	kappa	kappa	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	epsilon	epsilon	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	1	1	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Upon	upon	_	_	_	_	_	_	_
2	treatment	treatment	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	large	large	_	_	_	_	_	_	_
6	variety	variety	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	inducers	inducer	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	I	i	_	_	_	_	_	_	_
11	kappa	kappa	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	alpha	alpha	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	I	i	_	_	_	_	_	_	_
16	kappa	kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	beta	beta	_	_	_	_	_	_	_
19	are	be	_	_	_	_	_	_	_
20	proteolytically	proteolytically	_	_	_	_	_	_	_
21	degraded	degrade	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	resulting	result	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	NF-kappa	NF-kappa	_	_	_	_	_	_	_
26	B	B	_	_	_	_	_	_	_
27	translocation	translocation	_	_	_	_	_	_	_
28	into	into	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	nucleus	nucleus	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	E29.1	e29.1	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	hybridoma	hybridoma	_	_	_	_	_	_	_
10	I	i	_	_	_	_	_	_	_
11	kappa	kappa	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	alpha	alpha	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	I	i	_	_	_	_	_	_	_
16	kappa	kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	beta	beta	_	_	_	_	_	_	_
19	are	be	_	_	_	_	_	_	_
20	equally	equally	_	_	_	_	_	_	_
21	associated	associate	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	p65	p65	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	I	i	_	_	_	_	_	_	_
27	kappa	kappa	_	_	_	_	_	_	_
28	B	B	_	_	_	_	_	_	_
29	beta	beta	_	_	_	_	_	_	_
30	is	be	_	_	_	_	_	_	_
31	degraded	degrade	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	response	response	_	_	_	_	_	_	_
34	to	to	_	_	_	_	_	_	_
35	TNF	TNF	_	_	_	_	_	_	_
36	alpha	alpha	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	contrast	contrast	_	_	_	_	_	_	_
39	to	to	_	_	_	_	_	_	_
40	what	what	_	_	_	_	_	_	_
41	has	have	_	_	_	_	_	_	_
42	been	be	_	_	_	_	_	_	_
43	originally	originally	_	_	_	_	_	_	_
44	published	publish	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	also	also	_	_	_	_	_	_	_
4	suggest	suggest	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	unlike	unlike	_	_	_	_	_	_	_
8	I	i	_	_	_	_	_	_	_
9	kappa	kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	alpha	alpha	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	I	i	_	_	_	_	_	_	_
14	kappa	kappa	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	beta	beta	_	_	_	_	_	_	_
17	is	be	_	_	_	_	_	_	_
18	constitutively	constitutively	_	_	_	_	_	_	_
19	phosphorylated	phosphorylate	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	resynthesized	resynthesize	_	_	_	_	_	_	_
22	as	as	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	hypophosphorylated	hypophosphorylate	_	_	_	_	_	_	_
25	form	form	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	absence	absence	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	slow	slow	_	_	_	_	_	_	_
5	migrating	migrating	_	_	_	_	_	_	_
6	forms	form	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	I	i	_	_	_	_	_	_	_
9	kappa	kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	beta	beta	_	_	_	_	_	_	_
12	following	follow	_	_	_	_	_	_	_
13	stimulation	stimulation	_	_	_	_	_	_	_
14	suggests	suggest	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	phosphorylation	phosphorylation	_	_	_	_	_	_	_
18	does	do	_	_	_	_	_	_	_
19	not	not	_	_	_	_	_	_	_
20	necessarily	necessarily	_	_	_	_	_	_	_
21	constitute	constitute	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	signal-induced	signal-induced	_	_	_	_	_	_	_
24	event	event	_	_	_	_	_	_	_
25	which	which	_	_	_	_	_	_	_
26	targets	target	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	molecule	molecule	_	_	_	_	_	_	_
29	for	for	_	_	_	_	_	_	_
30	proteolysis	proteolysis	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

